| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 237.820 | 216.627 | 194.404 | 188.565 | 199.100 | 255.379 | 247.613 | 218.897 | 207.405 | 154.040 |
| Total Income - EUR | 237.920 | 220.151 | 194.830 | 188.568 | 199.198 | 255.381 | 251.168 | 219.021 | 207.408 | 240.707 |
| Total Expenses - EUR | 205.329 | 175.542 | 181.037 | 171.190 | 184.618 | 233.912 | 230.836 | 204.519 | 192.917 | 137.793 |
| Gross Profit/Loss - EUR | 32.592 | 44.609 | 13.793 | 17.377 | 14.581 | 21.468 | 20.333 | 14.501 | 14.490 | 102.913 |
| Net Profit/Loss - EUR | 27.343 | 37.471 | 11.634 | 15.301 | 12.422 | 18.908 | 17.728 | 12.206 | 12.719 | 86.768 |
| Employees | 4 | 4 | 5 | 5 | 5 | 4 | 4 | 3 | 2 | 2 |
Check the financial reports for the company - Farmalex Total S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.349 | 104 | -2.489 | 6.461 | 6.345 | 6.371 | 25.012 | 19.921 | 14.628 | 3.713 |
| Current Assets | 124.903 | 76.903 | 43.398 | 59.572 | 51.539 | 63.879 | 60.142 | 42.789 | 43.143 | 107.072 |
| Inventories | 16.504 | 29.742 | 23.172 | 26.539 | 31.300 | 29.528 | 26.131 | 25.190 | 20.342 | 0 |
| Receivables | 4.358 | 839 | 6.514 | 11.346 | 5.255 | 15.486 | 20.219 | 11.598 | 10.116 | 7.977 |
| Cash | 17.438 | 24.065 | 13.723 | 21.687 | 14.985 | 18.864 | 13.791 | 6.001 | 12.686 | 99.095 |
| Shareholders Funds | 72.157 | 37.592 | 11.765 | 26.850 | 27.554 | 19.032 | 17.849 | 12.328 | 13.518 | 86.889 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 57.095 | 39.415 | 29.144 | 39.183 | 30.330 | 51.218 | 67.305 | 50.382 | 44.253 | 25.342 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmalex Total S.r.l.